Product
LEP-F1 + GLA-SE
1 clinical trial
1 indication
Indication
LeprosyClinical trial
A Phase 1b / 2a, Double-Blind, Randomized, Placebo-Controlled, Antigen Dose-Escalation Clinical Trial to Evaluate the Safety, Tolerability, and Immunogenicity of LEP-F1 + GLA-SE in Adult Participants in Areas Endemic for LeprosyStatus: Not yet recruiting, Estimated PCD: 2024-03-01